EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Foundayo's Early Growth Is Raising Lilly (LLY)'s Revenue Expectations. But Can It Outrun Pricing Pressure?
Eli Lilly and Company (NYSE:LLY) Shares Climb 2.8% - What's Next? - Zolmax
Eli Lilly (LLY) vs. Novo Nordisk (NVO): Has the GLP-1 Race Changed the Moat?
FDA approves Lilly's Olumiant for pediatric patients 12 years of age and older with severe alopecia areata | INN
Why GLP-1 drugs are under fresh scrutiny over a rare eye condition linked to vision loss
Weekly Buzz: MESO, LLY, ANIP Win FDA Nod; KALA, HCTI Sign LOI; IMVT Halts Lupus Study
Analyzing Prestige Consumer Healthcare (NYSE:PBH) & Eli Lilly and Company (NYSE:LLY)
Viking Therapeutics Soared After Its Latest GLP-1 Data. Is It Too Late to Buy?
Jury awards $90M to Nektar in Lilly dispute over rezpeg | BioWorld
Eli Lilly and Company (NYSE:LLY) Stock Jumps 2.8% - Still a Buy?
Why we like Starbucks' latest turnaround move - plus, two more wins for Eli Lilly
Pharmaceutical Stocks To Follow Today - September 24th - Markets Daily
Healthcare Stocks To Watch Today - September 24th - Zolmax
Lilly extends China innovation push in $3.35B Innocare deal
Eli Lilly and Company (LLY) Stock: Rises After FDA Approves Weekly Insulin Drug
Lilly's latest China drug deal; Immunovant's setback in lupus
Eli Lilly's Onswik Weekly Insulin Wins FDA Approval For Treatment Of Type 2 Diabetes
Wealthy interests in Ohio and America entrench power in the name of philanthropy, report says
Awiqli insulin, this time for Lilly, with FDA-cleared Onswik | BioWorld
QRG Capital Management Inc. Buys 12,755 Shares of Eli Lilly and Company $LLY
Eli Lilly and Company $LLY Shares Acquired by Envestnet Portfolio Solutions Inc.
Eli Lilly and Company (NYSE:LLY) Shares Down 1.4% - Here's What Happened
Envestnet Portfolio Solutions Inc. Boosts Stake in Eli Lilly and Company $LLY - Stock Observer
Eli Lilly Vs. Pfizer in 2027: One Is a Much Better Place to Park Your Pharmaceutical Capital Next Year
Eli Lilly and Company (NYSE:LLY) Shares Down 1.4% - Should You Sell? - Daily Political
Healthcare Stocks To Add to Your Watchlist - September 23rd - Stock Observer
Free health screenings, clinical trial set | News | reflector.com
Roche's Enicepatide Achieves 15.5% Weight Loss in Type-2 Diabetes Patients - A Game Changer in Diabetes Treatment, ETPharma
Patients claim popular GLP-1 drugs led to permanent vision loss
Obesity Treatment Landscape 2026: Obesity Competitive Landscape and Clinical Trial Analysis 2026 Examines 200+ Companies and 200+ Drugs | Valuespectrum.com
State Street Corp Increases Position in Eli Lilly and Company $LLY
Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial - Update | Morningstar
Top Healthcare Stocks To Keep An Eye On - September 22nd - Stock Observer
Twist Bioscience (TWST) Expands AI Drug Discovery Exposure With Lilly TuneLab Partnership
Eli Lilly Breaks Ground On $6.5 Bln Houston Manufacturing Facility
Diabetic Peripheral Neuropathy Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Helixmith, Lexicon Pharma, Glenmark Pharma, Praetego | ABNewswire
Eli Lilly and Company (NYSE:LLY) Shares Up 1.1% - Here's Why
Eli Lilly and Planet Harvest bring brain healthy food to seniors
Silicon Valley Capital Partners Purchases 480 Shares of Eli Lilly and Company $LLY - Stock Observer
Best Pharmaceutical Stocks Worth Watching - September 21st - Stock Observer
Promising Healthcare Stocks To Consider - September 19th - Markets Daily
FDA Grants Full Approval To Lilly's Inluriyo Plus Verzenio For ESR1-Mutated Breast Cancer
Promising Healthcare Stocks To Follow Today - September 18th - Stock Observer
Eli Lilly and Company (NYSE:LLY) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
From Google to ByteDance: Why Every Major Tech Giant Will Eventually Own a Pharmaceutical Company
A Failed Cholesterol Drug Raises the Stakes for Amgen (AMGN) and Eli Lilly (LLY) Too
Top Pharmaceutical Stocks Worth Watching - September 17th - Markets Daily
Eli Lilly (LLY) Gets a Big Price Target Boost, Analysts See 20% Upside
Novo Nordisk (NVO) and Eli Lilly (LLY)'s Weight-Loss Drugs Still Work at Smaller Doses, Study Finds
Chronic Pain Market Poised for Growth Through 2036 as Rising Prevalence and Innovative Therapies Drive New Opportunities
This Trend is Excellent News for Eli Lilly and Its Investors
Ginkgo Datapoints Partners With Lilly TuneLab To Link AI Models And Lab Data
Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data | Morningstar
Best Healthcare Stocks To Follow Today - September 16th - Stock Observer
Eli Lilly and Company (NYSE:LLY) Rating Increased to Strong-Buy at Berenberg Bank
LB Pharmaceuticals Appoints Susan Kozauer As CMO
Eli Lilly Vs. Merck: One is a No-Brainer to Hold Through 2030
以下是本周二华尔街分析师发布的重点研究报告：Autodesk、礼来、Etsy、Lear、Netskope、诺基亚、诺斯罗普·格鲁曼、Rapid7、Rivian Automotive、Ulta Beauty 等
QurCan Therapeutics Enters Strategic Research and Collaboration Agreement with Lilly to Advance Nucleic Acid Therapies for Central and Peripheral Nervous System Diseases | Morningstar
What is Erste Group Bank's Forecast for NVO FY2026 Earnings? - Zolmax
Eli Lilly and Company (NYSE:LLY) Shares Up 2.1% - Still a Buy? - Stock Observer
Novo drops 'Nordisk' in corporate refresh to take on Lilly in the weight-loss wars | Morningstar
Top Pharmaceutical Stocks To Research - September 14th - Daily Political
Bank of America Corp DE Takes $13.52 Billion Position in Eli Lilly and Company $LLY
Novo Nordisk rebrands to 'Novo,' unveils corporate changes as it fights for obesity market share
OPKO Health (OPK) Cashes In A Future Royalty Stream Early
Rheumatoid Arthritis Market Outlook 2036: Advancements in Biologics and Emerging Therapies to Drive Market Growth Across the 7MM | ABNewswire
Pharmaceutical Stocks To Keep An Eye On - September 13th - Daily Political
Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC
Pharmaceutical Stocks To Follow Today - September 12th - Stock Observer
Sequoia Financial Advisors LLC Buys 11,238 Shares of Eli Lilly and Company $LLY - Markets Daily
The Manufacturers Life Insurance Company Reduces Stock Holdings in Eli Lilly and Company $LLY
Talon Private Wealth LLC Purchases New Holdings in Eli Lilly and Company $LLY
Eli Lilly and Company $LLY Stock Position Increased by Sequoia Financial Advisors LLC
Bullseye Investment Management LLC Takes $2.53 Million Position in Eli Lilly and Company $LLY
Bullseye Investment Management LLC Buys New Position in Eli Lilly and Company $LLY - Stock Observer
Eli Lilly's Immunology Push Builds New Growth Engines Beyond GLP-1s
RFG Advisory LLC Purchases 1,739 Shares of Eli Lilly and Company $LLY
Corient Private Wealth LP Lowers Stake in Eli Lilly and Company $LLY - Zolmax
Engineers Gate Manager LP Sells 17,317 Shares of Eli Lilly and Company $LLY
Eli Lilly and Company $LLY Shares Purchased by Integrated Wealth Concepts LLC
NewEdge Advisors LLC Increases Stake in Eli Lilly and Company $LLY
Eli Lilly and Company $LLY Stock Position Raised by IFP Advisors Inc
4,831 Shares in Eli Lilly and Company $LLY Purchased by Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD
Baird Financial Group Inc. Buys 20,340 Shares of Eli Lilly and Company $LLY
Eli Lilly and Company $LLY Shares Acquired by NewEdge Advisors LLC - Stock Observer
Teamwork Financial Advisors LLC Makes New $12.79 Million Investment in Eli Lilly and Company $LLY - Daily Political
The race for the next big weight-loss drug is on-and China wants in
Got $10,000? Eli Lilly vs. Nvidia: The Better Buy For 2026
Healthcare Stocks To Add to Your Watchlist - September 10th - Stock Observer
VIRGINIA RETIREMENT SYSTEMS ET Al Buys New Shares in Eli Lilly and Company $LLY - Markets Daily
Wellington Grp LLC Has $15.57 Million Holdings in Eli Lilly and Company $LLY - Zolmax
Eli Lilly and Company $LLY is Wellington Grp LLC's 6th Largest Position - Markets Daily
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
